The average Amphastar Pharmaceuticals Investor Relations earns an estimated $83,033 annually. Amphastar Pharmaceuticals' Investor Relations compensation is $1,102 more than the US average for a Investor Relations.
Last updated 2 years ago.
The majority of Investor Relations at Amphastar Pharmaceuticals believe they're not compensated fairly. 100% of Investor Relations at Amphastar Pharmaceuticals say they receive annual bonuses, and the vast majority (100%) are satisfied with their benefits. See more compensation ratings at Amphastar Pharmaceuticals